Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia

ClinicalTrials.gov ID: NCT05646719

Public ClinicalTrials.gov record NCT05646719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Masked, Placebo-Controlled, Multicenter, Phase 3 Study of the Safety and Efficacy of Nyxol (Phentolamine Ophthalmic Solution 0.75%) as a Single Agent and With Adjunctive Low-Dose Pilocarpine Hydrochloride Ophthalmic Solution 0.4% in Subjects With Presbyopia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are: To evaluate the safety and efficacy of Nyxol alone and with adjunctive low dose pilocarpine to improve distance-corrected near visual acuity (DCNVA) in subjects with presbyopia.

Study identification

NCT ID
NCT05646719
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Opus Genetics, Inc
Industry
Enrollment
333 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 22, 2022 (Actual)
Primary completion
Oct 11, 2023 (Actual)
Completion
Oct 11, 2023 (Actual)
Last update posted
Jul 13, 2026

2022 – 2023

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
26
Facility City State ZIP Site status
Phoenix, AZ Phoenix Arizona 85003 —
Azusa, CA Azusa California 91702 —
Newport Beach, CA Newport Beach California 92663 —
Northridge, CA Northridge California 91325 —
Delray Beach, FL Delray Beach Florida 33484 —
Longwood, FL Longwood Florida 32779 —
Roswell, GA Roswell Georgia 30076 —
Lake Villa, IL Lake Villa Illinois 60046 —
Pittsburg, KS Pittsburg Kansas 66762 —
Shawnee Mission, KS Shawnee Mission Kansas 66204 —
Bloomington, MN Bloomington Minnesota 55420 —
Chesterfield, MO Chesterfield Missouri 63017 —
Kansas City, MO Kansas City Missouri 64133 —
Saint Louis, MO St Louis Missouri 63128 —
Rochester, NY Rochester New York 14618 —
Smithtown, NY Smithtown New York 11787 —
Garner, NC Garner North Carolina 27529 —
Fargo, ND Fargo North Dakota 58103 —
Athens, OH Athens Ohio 45701 —
Cranberry Township, PA Cranberry Township Pennsylvania 16066 —
New Freedom, PA New Freedom Pennsylvania 17349 —
Sioux Falls, SD Sioux Falls South Dakota 57108 —
Memphis, TN Memphis Tennessee 38119 —
Austin, TX Austin Texas 73301 —
Houston, TX Houston Texas 77055 —
San Antonio, TX San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05646719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05646719 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →